NCT04534660View on ClinicalTrials.gov

Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 10, 2020

Primary Completion Date

August 24, 2021

Study Completion Date

June 23, 2023

Conditions
Nasolabial FoldCheek Augmentation
Interventions
DEVICE

SMI-01

SMI-01 is a device consisting of silk particles in a hydrogel carrier.

Trial Locations (2)

33137

Baumann Cosmetic & Research Institute, Miami

92024

California Dermatology & Clinical Research Institute, Encinitas

All Listed Sponsors
collaborator

Symbio, LLC

INDUSTRY

lead

Sofregen Medical, Inc.

INDUSTRY

NCT04534660 - Preliminary Safety and Effectiveness of SMI-01 as a Tissue Filler | Biotech Hunter | Biotech Hunter